Kenji Ikeda

29.5k total citations · 4 hit papers
409 papers, 16.5k citations indexed

About

Kenji Ikeda is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Kenji Ikeda has authored 409 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 265 papers in Hepatology, 193 papers in Epidemiology and 77 papers in Physiology. Recurrent topics in Kenji Ikeda's work include Hepatitis C virus research (166 papers), Liver Disease Diagnosis and Treatment (158 papers) and Hepatocellular Carcinoma Treatment and Prognosis (99 papers). Kenji Ikeda is often cited by papers focused on Hepatitis C virus research (166 papers), Liver Disease Diagnosis and Treatment (158 papers) and Hepatocellular Carcinoma Treatment and Prognosis (99 papers). Kenji Ikeda collaborates with scholars based in Japan, United States and China. Kenji Ikeda's co-authors include Hiromitsu Kumada, Yasuji Arase, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kuniaki Tsuchiya, Satoshi Saitoh, Norio Akuta, Haruhiko Akiyama and Tetsuya Hosaka and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

Kenji Ikeda

393 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

2006 2.1k citations Kenji Ikeda, Kuniaki Tsuchiya et al. profile →
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma

2009 872 citations Yujin Hoshida, Sebastian Nijman et al. Cancer Research profile →
UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis

2017 442 citations Kenji Ikeda, Takeshi Yoneshiro et al. profile →
The Common and Distinct Features of Brown and Beige Adipocytes

2018 409 citations Kenji Ikeda, Pema Maretich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenji Ikeda Japan	61	8.2k	7.3k	3.6k	3.3k	2.9k	409	16.5k
Keiji Sano Japan	63	3.5k 0.4×	2.5k 0.3×	974 0.3×	2.3k 0.7×	3.1k 1.1×	449	15.0k
Mathias Bähr Germany	43	2.6k 0.3×	3.4k 0.5×	410 0.1×	1.3k 0.4×	554 0.2×	168	7.0k
Takenobu Kamada Japan	56	2.9k 0.3×	3.0k 0.4×	1.3k 0.4×	2.4k 0.7×	361 0.1×	308	11.5k
Duncan J. Stewart Canada	70	441 0.1×	1.6k 0.2×	3.8k 1.1×	5.6k 1.7×	628 0.2×	345	19.3k
Kenji Ikeda Japan	42	3.7k 0.5×	4.3k 0.6×	977 0.3×	907 0.3×	497 0.2×	248	7.4k
Chantal M. Boulanger France	70	757 0.1×	1.6k 0.2×	4.2k 1.1×	7.5k 2.3×	195 0.1×	185	16.4k
Ralph T. Schermuly Germany	72	812 0.1×	1.0k 0.1×	3.2k 0.9×	5.8k 1.7×	158 0.1×	397	20.0k
Masatomo Mori Japan	54	1.1k 0.1×	1.6k 0.2×	1.0k 0.3×	3.1k 0.9×	163 0.1×	385	9.4k
Jitsuo Higaki Japan	62	982 0.1×	1.1k 0.1×	1.5k 0.4×	3.4k 1.0×	140 0.0×	422	12.7k
Gianfranco Alpini United States	75	6.4k 0.8×	4.0k 0.5×	910 0.3×	4.1k 1.2×	64 0.0×	353	15.9k

Countries citing papers authored by Kenji Ikeda

Since Specialization

Citations

This map shows the geographic impact of Kenji Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ikeda more than expected).

Fields of papers citing papers by Kenji Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ikeda. The network helps show where Kenji Ikeda may publish in the future.

Co-authorship network of co-authors of Kenji Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ikeda. A scholar is included among the top collaborators of Kenji Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ikeda. Kenji Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koga, Daisuke, Chikara Komiya, A. Takeuchi, et al.. (2025). Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiograms. Cardiovascular Diabetology. 24(1). 415–415.

Kawamura, Yusuke, Norio Akuta, Junichi Shindoh, et al.. (2022). Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma. Clinical Journal of Gastroenterology. 16(1). 1–12. 5 indexed citations

Okusaka, Takuji, Masatoshi Kudo, Kenji Ikeda, et al.. (2022). Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma. Hepatology Research. 52(9). 784–793. 1 indexed citations

Okusaka, Takuji, Kenji Ikeda, Masatoshi Kudo, et al.. (2021). Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. Journal of Gastroenterology. 56(6). 570–580. 10 indexed citations

Saitoh, Satoshi, Norio Akuta, Shunichiro Fujiyama, et al.. (2019). Long‐term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus‐related liver cirrhosis after interferon‐based therapy. Hepatology Research. 49(12). 1441–1450. 11 indexed citations

Lü, Xiaodan, Svetlana Altshuler-Keylin, Qiang Wang, et al.. (2018). Mitophagy controls beige adipocyte maintenance through a Parkin-dependent and UCP1-independent mechanism. Science Signaling. 11(527). 104 indexed citations

Kawamura, Yusuke, Hitomi Sezaki, Tetsuya Hosaka, et al.. (2014). Rapid and high sensitive detection of Y93H amino acid substitution in HCV NS5A region using the PCR-Invader assay. Kanzo. 55(11). 720–722. 12 indexed citations

Kitamura, Yuji, Hiroshi Shiga, Kenji Ikeda, et al.. (2011). Effectiveness of systemic chemotherapy using CBDCA and 5-FU in a case of hepatocellular carcinoma with metastases to the lung. Kanzo. 52(1). 42–49.

Imai, Norihiro, Kenji Ikeda, Yuya Seko, et al.. (2010). Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis. Kanzo. 51(12). 758–760. 1 indexed citations

10.

Hoshida, Yujin, Sebastian Nijman, Masahiro Kobayashi, et al.. (2009). Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma. Cancer Research. 69(18). 7385–7392. 872 indexed citations breakdown →

11.

Kobayashi, Mariko, Fumitaka Suzuki, Norio Akuta, et al.. (2009). Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels. Scandinavian Journal of Gastroenterology. 44(8). 975–983. 5 indexed citations

12.

Kobayashi, Mariko, Norio Akuta, Fumitaka Suzuki, et al.. (2009). Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b. Journal of Medical Virology. 82(1). 41–48. 21 indexed citations

13.

Sezaki, Hitomi, Fumitaka Suzuki, Norio Akuta, et al.. (2008). Influence of HMG-CoA reductase inhibitor to virological response of peginterferon/ribavirin combination therapy in chronic hepatitis C. Kanzo. 49(1). 22–24. 3 indexed citations

14.

Akuta, Norio, Yoshiyuki Suzuki, Tetsuya Hosaka, et al.. (2007). Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test. Kanzo. 48(8). 382–383.

15.

Ikeda, Kenji. (2005). Forefront of radiofrequency ablation treatment of hepatic cancer. 2. Comparison of the equipment for radiofrequency ablation therapy.. Kanzo. 46(4). 165–168. 1 indexed citations

16.

Uchihara, Toshiki, Kenji Ikeda, & Kuniaki Tsuchiya. (2003). Pick body disease and Pick syndrome*. Neuropathology. 23(4). 318–326. 27 indexed citations

17.

Suzuki, Yoshiyuki, Kenji Ikeda, Satoshi Saitoh, et al.. (1997). Long-term observation of four patients with early stage of primary biliary cirrhosis(PBC).. Kanzo. 38(2). 96–100.

18.

Saitô, Satoshi, Kenji Ikeda, Isao Koida, et al.. (1993). Early diagnosis of small hepatocellular carcinoma with PIVKA-II determined by Abidin-Biotin complex method.. Kanzo. 34(8). 591–596. 1 indexed citations

19.

Arase, Yasuji, Hiromitsu Kumada, Kazuaki Chayama, et al.. (1991). Interferon therapy for chronic hepatitis C.. Kanzo. 32(2). 131–135. 6 indexed citations

20.

Ikeda, Kenji, Akio Nakashima, Hiroshi Fujita, Akihiko Ikeda, & Mitsuhiro Tsukino. (1990). Two operated cases of small bowel metastases from primary lung cancer.. Haigan. 30(6). 921–927. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact